Re:Build Manufacturing
Re:Build Optimation is seeking an Automation & Controls Engineer Co-op/Intern to support real-world industrial automation projects from concept through production. The role involves collaborating with engineering and project management teams to develop control system architectures, create electrical drawings, and configure PLC code and HMI applications. This on-site position in Rochester, NY, and/or Rush, NY offers hands-on experience and mentorship from senior engineers across Spring, Summer, and Fall 2027.
Headquarters
Framingham, Massachusetts, United States
Company Size
501-1000 employees
Founded
2020
Re:Build Manufacturing is a family of industrial businesses focused on "rekindling American industry." The group operates and invests in manufacturing companies across Aerospace & Defense, Electrification, Energy & Environment, Medical, and Robotics & Intelligent Automation. Re:Build builds and scales advanced domestic production capabilities, combining engineering, automation, and operational expertise to support reshoring, supply‑chain resilience, and commercialization of advanced technologies.
Re:Build Manufacturing Launches Ensorcell to Engineer and Manufacture Innovative and Affordable Life Science Tools
Nov 11, 2025
Re:Build Manufacturing achieves CMMC Level 2 certification
1 month ago
Re:Build Manufacturing at New Ken Advanced Manufacturing Park: Charting a course for American manufacturing, lifting up a community
Sep 4, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Re:Build Manufacturing.
34% below the average for this role
Foundation Alloy and Re:Build Manufacturing Launch Engineering Partnership to Fast-Track Scale-Up and Automation
Aug 28, 2025